TradingKey

關於 Neogenomics Inc 公司

NeoGenomics, Inc. 提供一系列腫瘤診斷測試和諮詢服務，包括技術實驗室服務。該公司由專門從事病理學和腫瘤學的執業醫師提供對實驗室測試結果的專業解釋。其部門包括臨牀服務和高級診斷。臨牀服務部門包括臨牀癌症檢測；解釋和諮詢服務；分子和 NGS 檢測，以及全面的技術和專業服務。其臨牀服務客戶包括社區病理學和腫瘤學診所、醫院病理學實驗室、參考實驗室和學術中心。高級診斷部門包括臨牀試驗和研究、驗證實驗室服務和信息學。其高級診斷客戶包括製藥公司，該公司爲其提供測試和其他服務以支持其研究和臨牀試驗。

公司簡介

公司代碼NEO

公司名稱Neogenomics Inc

上市日期Dec 10, 2012

CEOMr. Antony P. Zook

員工數量2200

證券類型Ordinary Share

年結日Dec 10

公司地址9490 Neogenomics Way

城市FORT MYERS

上市交易所NASDAQ Capital Market Consolidated

國家United States of America

郵編33912

電話12397680600

網址https://neogenomics.com/

公司代碼NEO

上市日期Dec 10, 2012

CEOMr. Antony P. Zook

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Jeffrey Scott (Jeff) Sherman

Chief Financial Officer

166.66K

+21.81%

Mr. Warren Stone

President, Chief Operating Officer

108.28K

+19.26%

Mr. Stephen Michael Kanovsky

Independent Director

52.34K

+30.57%

Dr. Neil Gunn

Independent Director

28.10K

+77.33%

Ms. Elizabeth Floegel

Independent Director

23.59K

+108.10%

Ms. Felicia Williams

Independent Director

7.16K

--

Ms. Marjorie C. Green

Independent Director

--

Mr. David B. Perez

Independent Director

--

Ms. Alicia Olivo

Executive Vice President, General Counsel & Business Development

--

Mr. Michael A. Kelly

Lead Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Jeffrey Scott (Jeff) Sherman

Chief Financial Officer

166.66K

+21.81%

Mr. Warren Stone

President, Chief Operating Officer

108.28K

+19.26%

Mr. Stephen Michael Kanovsky

Independent Director

52.34K

+30.57%

Dr. Neil Gunn

Independent Director

28.10K

+77.33%

Ms. Elizabeth Floegel

Independent Director

23.59K

+108.10%

Ms. Felicia Williams

Independent Director

7.16K

--

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Clinical Services-Client direct billing

122.04M

72.63%

Clinical Services-Commercial Insurance

24.86M

14.79%

Clinical Services-Medicare and Medicaid

21.10M

12.56%

Clinical Services-Self-Pay

39.00K

0.02%

暫無數據

業務

地區

業務USD

名稱

營收

佔比

Clinical Services-Client direct billing

122.04M

72.63%

Clinical Services-Commercial Insurance

24.86M

14.79%

Clinical Services-Medicare and Medicaid

21.10M

12.56%

Clinical Services-Self-Pay

39.00K

0.02%

股東統計

更新時間: 5月14日週三

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

14.16%

The Vanguard Group, Inc.

11.01%

First Light Asset Management, LLC

4.68%

Janus Henderson Investors

4.44%

State Street Global Advisors (US)

3.94%

Other

61.77%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

14.16%

The Vanguard Group, Inc.

11.01%

First Light Asset Management, LLC

4.68%

Janus Henderson Investors

4.44%

State Street Global Advisors (US)

3.94%

Other

61.77%

股東類型

持股股東

佔比

Investment Advisor

50.11%

Investment Advisor/Hedge Fund

37.15%

Hedge Fund

7.37%

Research Firm

1.52%

Individual Investor

1.19%

Pension Fund

1.13%

Bank and Trust

0.58%

Sovereign Wealth Fund

0.39%

Insurance Company

0.04%

Other

0.51%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

569

127.92M

99.03%

-12.74M

2025Q1

596

131.44M

102.13%

-4.71M

2024Q4

585

127.59M

99.32%

-7.82M

2024Q3

589

129.38M

100.96%

-8.76M

2024Q2

597

131.21M

102.74%

-9.36M

2024Q1

633

132.83M

104.04%

-13.13M

2023Q4

672

130.90M

102.70%

-12.18M

2023Q3

691

124.98M

98.00%

-16.78M

2023Q2

691

121.76M

95.45%

-23.63M

2023Q1

704

120.14M

94.21%

-27.80M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

18.29M

14.21%

-356.84K

-1.91%

Mar 31, 2025

The Vanguard Group, Inc.

14.23M

11.06%

+17.23K

+0.12%

Mar 31, 2025

First Light Asset Management, LLC

6.04M

4.7%

+2.88M

+90.77%

Mar 31, 2025

Janus Henderson Investors

5.74M

4.46%

-424.04K

-6.88%

Mar 31, 2025

State Street Global Advisors (US)

5.09M

3.95%

-109.12K

-2.10%

Mar 31, 2025

Greenhouse Funds LLLP

4.71M

3.66%

+6.43K

+0.14%

Mar 31, 2025

Macquarie Investment Management

4.68M

3.63%

+864.39K

+22.67%

Mar 31, 2025

Schroder Investment Management North America Inc.

4.31M

3.35%

+509.99K

+13.42%

Mar 31, 2025

Brown Advisory

3.87M

3.01%

-2.28M

-37.10%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

3.85M

2.99%

+408.27K

+11.88%

Mar 31, 2025

持股ETF

更新時間: 8月2日週六

機構名稱

佔比

SPDR S&P Health Care Services ETF

1.78%

Invesco S&P SmallCap Health Care ETF

0.67%

WisdomTree BioRevolution Fund

0.63%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.34%

iShares U.S. Healthcare Providers ETF

0.15%

Inspire Small/Mid Cap ESG ETF

0.15%

Federated Hermes MDT Small Cap Core ETF

0.12%

Nuveen ESG Small-Cap ETF

0.09%

iShares ESG Select Screened S&P Small-Cap ETF

0.08%

SPDR S&P 600 Small Cap Value ETF

0.08%

SPDR S&P Health Care Services ETF

佔比1.78%

Invesco S&P SmallCap Health Care ETF

佔比0.67%

WisdomTree BioRevolution Fund

佔比0.63%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比0.34%

iShares U.S. Healthcare Providers ETF

佔比0.15%

Inspire Small/Mid Cap ESG ETF

佔比0.15%

Federated Hermes MDT Small Cap Core ETF

佔比0.12%

Nuveen ESG Small-Cap ETF

佔比0.09%

iShares ESG Select Screened S&P Small-Cap ETF

佔比0.08%

SPDR S&P 600 Small Cap Value ETF

佔比0.08%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Neogenomics Inc

5.410USD

Neogenomics Inc

5.410

概覽

公司

財務